Oncopeptides AB (publ) ONCO.ST
ONCO.ST
Oncopeptides AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) SYNACT.ST
SynAct Pharma AB ITECH.ST
I-Tech AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) CRAD-B.ST
C-Rad AB (publ) SEZI.ST
Senzime AB (publ) CANTA.ST
Cantargia AB (publ) GENO.ST
Genovis AB (publ.)
Oncopeptides AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) SYNACT.ST
SynAct Pharma AB ITECH.ST
I-Tech AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) CRAD-B.ST
C-Rad AB (publ) SEZI.ST
Senzime AB (publ) CANTA.ST
Cantargia AB (publ) GENO.ST
Genovis AB (publ.)
Performance
| Periode | ONCO.ST | XSPRAY.ST | SYNACT.ST | ITECH.ST | IBT-B.ST | DMYD-B.ST | CRAD-B.ST | SEZI.ST | CANTA.ST | GENO.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 157.87 % | -30.14 % | 12.01 % | -9.27 % | 26.35 % | 41.77 % | 11.51 % | 27.07 % | 52.23 % | 14.68 % |
| YTD | 221.52 % | -42.05 % | 121.39 % | 20.67 % | 6.10 % | -36.93 % | 11.32 % | 2.28 % | 40.59 % | -5.53 % |
| 1Y | 146.60 % | -56.63 % | 132.85 % | 46.56 % | 75.00 % | -19.22 % | -9.97 % | -4.28 % | -22.15 % | 2.90 % |
| 3Y | -42.47 % | -56.03 % | -57.84 % | 46.56 % | 8.56 % | -18.05 % | -6.13 % | -28.06 % | -34.95 % | -37.70 % |
| 5Y | -95.78 % | -81.32 % | -55.39 % | 3.72 % | -58.80 % | -67.64 % | -18.84 % | -73.18 % | -95.73 % | -25.04 % |
| 10Y | -83.42 % | -18.79 % | 314.74 % | 193.47 % | 4.17 % | 77.02 % | 83.34 % | 61.87 % | -69.85 % | 1 255.88 % |
| From the beginning | -83.42 % | -18.79 % | 314.74 % | 193.47 % | 4.17 % | 227.65 % | 131.31 % | -12.86 % | -71.86 % | -52.90 % |